Literature DB >> 12520027

Active Sequences Collection (ASC) database: a new tool to assign functions to protein sequences.

Angelo M Facchiano1, Antonio Facchiano, Francesco Facchiano.   

Abstract

Active Sequences Collection (ASC) is a collection of amino acid sequences, with an unique feature: only short sequences are collected, with a demonstrated biological activity. The current version of ASC consists of three sections: DORRS, a collection of active RGD-containing peptides; TRANSIT, a collection of protein regions active as substrates of transglutaminase enzyme (TGase), and BAC, a collection of short peptides with demonstrated biological activity. Literature references for each entry are reported, as well as cross references to other databases, when available. The current version of ASC includes more than 800 different entries. The main scope of this collection is to offer a new tool to investigate the structural features of protein active sites, additionally to similarity searches against large protein databases or searching for known functional patterns. ASC database is available at the web address http://crisceb.unina2.it/ASC/ which also offers a dedicated query interface to compare user-defined protein sequences with the database, as well as an updating interface to allow contribution of new referenced active sequences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520027      PMCID: PMC165489          DOI: 10.1093/nar/gkg042

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation.

Authors:  S R Adderley; D J Fitzgerald
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 2.  Arg-gly-Asp (RGD) peptides and peptidomimetics as therapeutics: relevance for renal diseases.

Authors:  M A Horton
Journal:  Exp Nephrol       Date:  1999 Mar-Apr

Review 3.  Moonlighting proteins.

Authors:  C J Jeffery
Journal:  Trends Biochem Sci       Date:  1999-01       Impact factor: 13.807

4.  Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Authors:  S Oliverio; A Amendola; F Di Sano; M G Farrace; L Fesus; Z Nemes; L Piredda; A Spinedi; M Piacentini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 5.  Snake venoms and the hemostatic system.

Authors:  F S Markland
Journal:  Toxicon       Date:  1998-12       Impact factor: 3.033

Review 6.  RGD and other recognition sequences for integrins.

Authors:  E Ruoslahti
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

7.  RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys.

Authors:  X Chen; J Wang; B Fu; L Yu
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

8.  RGD peptides induce apoptosis by direct caspase-3 activation.

Authors:  C D Buckley; D Pilling; N V Henriquez; G Parsonage; K Threlfall; D Scheel-Toellner; D L Simmons; A N Akbar; J M Lord; M Salmon
Journal:  Nature       Date:  1999-02-11       Impact factor: 49.962

9.  Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis.

Authors:  A Urtreger; F Porro; L Puricelli; S Werbajh; F E Baralle; E Bal de Kier Joffé; A R Kornblihtt; A F Muro
Journal:  Int J Cancer       Date:  1998-10-05       Impact factor: 7.396

10.  Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.

Authors:  J A Peterson; J R Couto; M R Taylor; R L Ceriani
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

View more
  7 in total

1.  ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins.

Authors:  Pål Puntervoll; Rune Linding; Christine Gemünd; Sophie Chabanis-Davidson; Morten Mattingsdal; Scott Cameron; David M A Martin; Gabriele Ausiello; Barbara Brannetti; Anna Costantini; Fabrizio Ferrè; Vincenza Maselli; Allegra Via; Gianni Cesareni; Francesca Diella; Giulio Superti-Furga; Lucjan Wyrwicz; Chenna Ramu; Caroline McGuigan; Rambabu Gudavalli; Ivica Letunic; Peer Bork; Leszek Rychlewski; Bernhard Küster; Manuela Helmer-Citterich; William N Hunter; Rein Aasland; Toby J Gibson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Authors:  Zsolt Keresztessy; Eva Csosz; Jolán Hársfalvi; Krisztián Csomós; Joe Gray; Robert N Lightowlers; Jeremy H Lakey; Zoltán Balajthy; László Fésüs
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

3.  Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.

Authors:  M Sorice; B Buttari; A Capozzi; E Profumo; F Facchiano; S Truglia; S Recalchi; C Alessandri; F Conti; R Misasi; G Valesini; R Riganò
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

4.  High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.

Authors:  C Marchetti; A Di Carlo; F Facchiano; C Senatore; R De Cristofaro; A Luzi; M Federici; M Romani; M Napolitano; M C Capogrossi; A Germani
Journal:  Diabetologia       Date:  2011-06-08       Impact factor: 10.122

Review 5.  Biocatalysis by Transglutaminases: A Review of Biotechnological Applications.

Authors:  Maria Pia Savoca; Elisa Tonoli; Adeola G Atobatele; Elisabetta A M Verderio
Journal:  Micromachines (Basel)       Date:  2018-10-31       Impact factor: 2.891

6.  Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis.

Authors:  Uno Tagami; Nobuhisa Shimba; Mina Nakamura; Kei-Ichi Yokoyama; Ei-Ichiro Suzuki; Takatsugu Hirokawa
Journal:  Protein Eng Des Sel       Date:  2009-10-22       Impact factor: 1.650

7.  Resveratrol prevents dendritic cell maturation in response to advanced glycation end products.

Authors:  Brigitta Buttari; Elisabetta Profumo; Francesco Facchiano; Elif Inci Ozturk; Luca Segoni; Luciano Saso; Rachele Riganò
Journal:  Oxid Med Cell Longev       Date:  2013-07-09       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.